The development marks the company's first acquisition in the overseas market. Commenting on the acquisition the company said"This deal enables GVK Biosciences to expand its service offering to a broader base of organizations and gives GVK Bio expertise in biologics services and a significant US presence".

Further, through the acquisition, GVK Biosciences' gains know-how in large molecule R&D services together with a wide array of high-content biologics services. The acquisition will also strengthen the position of GVK as the major company providing integrated R&D services across small as well as large molecule platforms.

GoodReturns.in